121 related articles for article (PubMed ID: 19104412)
1. Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience.
Tan HP; Donaldson J; Ellis D; Moritz ML; Basu A; Morgan C; Vats AN; Erkan E; Shapiro R
Transplantation; 2008 Dec; 86(12):1725-31. PubMed ID: 19104412
[TBL] [Abstract][Full Text] [Related]
2. Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation.
Tan HP; Kaczorowski D; Basu A; McCauley J; Marcos A; Donaldson J; Unruh M; Randhawa P; Zeevi A; Shapiro R
Transplant Proc; 2005 Dec; 37(10):4235-40. PubMed ID: 16387087
[TBL] [Abstract][Full Text] [Related]
3. Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up.
Tan HP; Donaldson J; Basu A; Unruh M; Randhawa P; Sharma V; Morgan C; McCauley J; Wu C; Shah N; Zeevi A; Shapiro R
Am J Transplant; 2009 Feb; 9(2):355-66. PubMed ID: 19120078
[TBL] [Abstract][Full Text] [Related]
4. Alemtuzumab induction with tacrolimus monotherapy in de novo renal transplantation.
Villanueva ME; Muñoz AS; Casasola CC; Africa JB; Danguilan RA; Ona ET
Transplant Proc; 2008 Sep; 40(7):2222-5. PubMed ID: 18790198
[TBL] [Abstract][Full Text] [Related]
5. Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation.
Sampaio MS; Kadiyala A; Gill J; Bunnapradist S
Transplantation; 2009 Oct; 88(7):904-10. PubMed ID: 19935462
[TBL] [Abstract][Full Text] [Related]
6. Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells.
Morales J; Bono MR; Fierro A; Iñiguez R; Zehnder C; Rosemblatt M; Calabran L; Herzog C; Benavente D; Aguiló J; Pefaur J; Alba A; Ferrario M; Simon W; Contreras L; Buckel E
Transplant Proc; 2008 Nov; 40(9):3223-8. PubMed ID: 19010240
[TBL] [Abstract][Full Text] [Related]
7. Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy.
Tan HP; Kaczorowski DJ; Basu A; Unruh M; McCauley J; Wu C; Donaldson J; Dvorchik I; Kayler L; Marcos A; Randhawa P; Smetanka C; Starzl TE; Shapiro R
Am J Transplant; 2006 Oct; 6(10):2409-17. PubMed ID: 16889606
[TBL] [Abstract][Full Text] [Related]
8. Alemtuzumab induction in kidney transplantation.
Huang E; Cho YW; Shah T; Peng A; Hayashi R; Bunnapradist S
Clin Transpl; 2005; ():343-54. PubMed ID: 17424750
[TBL] [Abstract][Full Text] [Related]
9. Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation.
Shapiro R; Ellis D; Tan HP; Moritz ML; Basu A; Vats AN; Kayler LK; Erkan E; McFeaters CG; James G; Grosso MJ; Zeevi A; Gray EA; Marcos A; Starzl TE
Am J Transplant; 2007 Dec; 7(12):2736-8. PubMed ID: 17908272
[TBL] [Abstract][Full Text] [Related]
10. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
11. Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China.
Yuan-Xin L; Ning L; You-Sheng L; Xiao-Dong N; Ming L; Jian W; Jie-Shou L
Transplant Proc; 2010; 42(1):29-34. PubMed ID: 20172275
[TBL] [Abstract][Full Text] [Related]
12. Reversal of acute cellular rejection after renal transplantation with Campath-1H.
Basu A; Ramkumar M; Tan HP; Khan A; McCauley J; Marcos A; Fung JJ; Starzl TE; Shapiro R
Transplant Proc; 2005 Mar; 37(2):923-6. PubMed ID: 15848576
[TBL] [Abstract][Full Text] [Related]
13. Alemtuzumab induction with tacrolimus monotherapy in 25 pediatric renal transplant recipients.
Sung J; Barry JM; Jenkins R; Rozansky D; Iragorri S; Conlin M; Al-Uzri A
Pediatr Transplant; 2013 Dec; 17(8):718-25. PubMed ID: 24164824
[TBL] [Abstract][Full Text] [Related]
14. Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience.
Tan HP; Kaczorowski DJ; Basu A; Khan A; McCauley J; Marcos A; Fung JJ; Starzl TE; Shapiro R
Transplantation; 2004 Dec; 78(11):1683-8. PubMed ID: 15591960
[TBL] [Abstract][Full Text] [Related]
15. Alemtuzumab induction in deceased donor kidney transplantation.
Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
[TBL] [Abstract][Full Text] [Related]
16. Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy.
Ellis D; Shapiro R; Moritz M; Vats A; Basu A; Tan H; Kayler L; Janosky J; Starzl TE
Transplantation; 2007 Jun; 83(12):1563-70. PubMed ID: 17589338
[TBL] [Abstract][Full Text] [Related]
17. Campath induction for kidney transplantation: report of 297 cases.
Ortiz J; Palma-Vargas J; Wright F; Bingaman A; Agha I; Rosenblatt S; Foster P
Transplantation; 2008 Jun; 85(11):1550-6. PubMed ID: 18551058
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of rapid steroid elimination with alemtuzumab induction therapy in kidney and pancreas transplantation.
Sundberg AK; Roskopf JA; Hartmann EL; Farney AC; Rohr MS; Stratta RJ
Transplant Proc; 2005 Mar; 37(2):1294-6. PubMed ID: 15848701
[TBL] [Abstract][Full Text] [Related]
19. Experience with Alemtuzumab (Campath-1H) as induction agent in renal transplantation followed by steroid-free immunosuppression.
Baez Y; Giron F; Niño-Murcia A; Rodríguez J; Salcedo S
Transplant Proc; 2008 Apr; 40(3):697-9. PubMed ID: 18454990
[TBL] [Abstract][Full Text] [Related]
20. Treatment of simultaneous acute antibody-mediated rejection and acute cellular rejection with alemtuzumab in kidney transplantation: a case report.
Jirasiritham S; Khunprakant R; Techawathanawanna N; Jirasiritham S; Mavichak V
Transplant Proc; 2010 Apr; 42(3):987-9. PubMed ID: 20430222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
